Texas Capital Bank Wealth Management Services Inc
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1802655
Dallas, TX
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$213,097
New position
Shares Held
429
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,394
of 1,735 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 73%
Shared 27%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Texas Capital Bank Wealth Management Services Inc holds $2,619,615 across 9 Biotechnology names. VRTX ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CUE |
Cue Biopharma, Inc.
|
22,881 | $722,124 | |
| 2 | IRD |
Opus Genetics, Inc.
|
122,529 | $503,594 | |
| 3 | RNTX |
Rein Therapeutics, Inc.
|
300,758 | $312,787 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
3,527 | $306,672 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
429 | $213,097 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
329 | $205,144 | |
| 7 | CGTX |
Cognition Therapeutics Inc
|
143,296 | $164,790 | |
| 8 | ACTU |
Actuate Therapeutics, Inc.
|
102,612 | $156,995 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,097 | 429 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||